Sonchuside A;(+)-Sonchuside A



Compound IDCDAMM00509
Common nameSonchuside A;(+)-Sonchuside A
IUPAC name3,6,10-trimethyl-9-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3a,4,5,8,9,11a-hexahydro-3H-cyclodeca[b]furan-2-one
Molecular formulaC21H32O8

Experimental data

Retention time12.27
Adduct[M+H]+
Actual mz413.221
Theoretical mz413.217
Error9.5
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.3859

Identifiers and class information

Inchi keyOWPORVMZZJAHEF-LDTFBSTDNA-N
SmilesO=C1OC2C=C(C)C(OC3OC(CO)C(O)C(O)C3O)CC=C(C)CCC2C1C
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)7
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)412.479
Computed dipole moment(dipole)4.78
Total solvent accessible surface area (SASA)667.407
Hydrophobic component of SASA (FOSA)427.793
Hydrophilic component of SASA (FISA)220.696
Pie component of the SASA (PISA)18.918
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1254.67
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)13.2
Free energy of solvation of dipole (dip^2/V)0.0182102
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0395561
Globularity descriptor (glob)0.842933
Predicted polarizability in cubic angstroms (QPpolrz)39.744
Predicted hexadecane/gas partition coefficient (QPlogPC16)12.461
Predicted octanol/gas partition coefficient (QPlogPoct)26.38
Predicted water/gas partition coefficient (QPlogPw)20.271
Predicted octanol/water partition coefficient (QPlogPo/w)0.102
Predicted aqueous solubility (QPlogS)-3.161
Conformation-independent predicted aqueous solubility (CIQPlogS)-2.338
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.164
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)79.991
Predicted brain/blood partition coefficient (QPlogBB)-1.929
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)32.26
Predicted skin permeability, log Kp (QPlogKp)-4.848
PM3 calculated ionization potential (IP(ev))9.696
PM3 calculated electron affinity (EA(eV))-0.493
Number of likely metabolic reactions (#metab)11
Prediction of binding to human serum albumin (QPlogKhsa)-0.591
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)61.603
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)140.928
Number of nitrogen and oxygen atoms (#NandO)8
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q9BZP6CHIAAcidic mammalian chitinase (by homology)T51597SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P60568IL2Interleukin-2T61698SEA
P17931LGALS3Galectin-3T72038SEA
P04746AMY2APancreatic alpha-amylaseT86918SEA
P14679TYRTyrosinaseT97035SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
Q99417MYCBPMYCBP messenger RNAT37298SEA
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T72038DI0190Hypertension[ICD-11: BA00-BA04]P17931LGALS3
T72038DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]P17931LGALS3
T72038DI0252Melanoma[ICD-11: 2C30]P17931LGALS3
T72038DI0302Non-alcoholic fatty liver disease[ICD-11: DB92]P17931LGALS3
T72038DI0351Psoriasis[ICD-11: EA90]P17931LGALS3
T86918DI0110Cystic fibrosis[ICD-11: CA25]P04746AMY2A
T86918DI0328Pancreatic malfunction[ICD-11: DC30-DC3Z]P04746AMY2A
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T37298DI0235Liver cancer[ICD-11: 2C12]Q99417MYCBP
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1

Copyright © 2025